InDex Pharmaceuticals utvecklar cobitolimod, ett nytt läkemedel för inflammatorisk tarmsjukdom som kan hjälpa patienter tillbaka till ett normalt liv.
Joined June 2016
- Tweets 249
- Following 6
- Followers 247
- Likes 1
10 Photos and videos
26 Apr 2023
Välkommen till InDex Pharmaceuticals Business Update-presentation i Stockholm den 9 maj, kl 13:00 till 15.30 CET news.cision.com/se/index-pha…
293
26 Apr 2023
Welcome to an InDex Pharmaceuticals business update presentation in Stockholm on May 9, from 13:00 to 15.30 CET news.cision.com/index-pharma…
1
262
19 Apr 2023
InDex Pharmaceuticals Holding AB (publ) kallar till årsstämma news.cision.com/se/index-pha…
235
19 Apr 2023
Notice of Annual General Meeting in InDex Pharmaceuticals Holding AB (publ) news.cision.com/index-pharma…
183
12 Apr 2023
InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2022 news.cision.com/index-pharma…
158
12 Apr 2023
InDex Pharmaceuticals Holding AB (publ) offentliggör årsredovisning för 2022 news.cision.com/se/index-pha…
136
15 Mar 2023
InDex Pharmaceuticals meddelar positiva resultat från en farmakokinetikstudie (PK-studie) med cobitolimod news.cision.com/se/index-pha…
2
123
15 Mar 2023
InDex Pharmaceuticals announces positive results from a pharmacokinetic (PK) study with cobitolimod news.cision.com/index-pharma…
1
91
23 Feb 2023
InDex Pharmaceuticals Holding AB (publ) bokslutskommuniké 2022 news.cision.com/se/index-pha…
84
23 Feb 2023
InDex Pharmaceuticals Holding AB (publ) year-end report 2022 news.cision.com/index-pharma…
70
14 Feb 2023
InDex Pharmaceuticals tillhandahåller kompletterande information om fas III-programmet CONCLUDE med cobitolimod news.cision.com/se/index-pha…
1
96
14 Feb 2023
InDex Pharmaceuticals provides complementary information on the phase III program CONCLUDE with cobitolimod news.cision.com/index-pharma…
65
27 Jan 2023
InDex Pharmaceuticals uppdaterar tidplanen för fas III-studien CONCLUDE med cobitolimod news.cision.com/se/index-pha…
133
27 Jan 2023
InDex Pharmaceuticals updates the timeline of the phase III study CONCLUDE with cobitolimod news.cision.com/index-pharma…
72
23 Nov 2022
InDex Pharmaceuticals Holding AB (publ) interim report January – September 2022 news.cision.com/index-pharma…
23 Nov 2022
InDex Pharmaceuticals Holding AB (publ) delårsrapport för januari – september 2022 news.cision.com/se/index-pha…
26 Oct 2022
InDex Pharmaceuticals Holding AB (publ) offentliggör valberedning inför årsstämman 2023 news.cision.com/se/index-pha…
26 Oct 2022
InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2023 Annual General Meeting news.cision.com/index-pharma…